Funder
United Therapeutics Corporation
Publisher
Public Library of Science (PLoS)
Reference40 articles.
1. The limits of oral therapy in pulmonary arterial hypertension management;QQ Liu;Ther. Clin. Risk. Manag,2015
2. Pathology of pulmonary hypertension;RM Tuder;Clin. Chest Med,2013
3. Efficacy and safety of PAH-specific therapy in pulmonary arterial hypertension: a meta-analysis of randomized clinical trials;HL Liu;Chest,2016
4. Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension;A Yamamura;J. Smooth Muscle Res,2014
5. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial;VF Tapson;Chest,2013
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献